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Virendra I. Patel, Robert T. Lancaster, Shankha Mukhopadhyay, Nathan J.
Aranson, Mark F. Conrad, Glenn M. LaMuraglia, Christopher J. Kwolek,
Richard P. Cambria
Objective: Chronic kidney disease (CKD) is associated with increased
morbidity and death after open abdominal aortic aneurysm (AAA) repair
(OAR). This study highlights the effect of CKD on outcomes after endo-
vascular AAA (EVAR) and OAR in contemporary practice.
Methods: The National Surgical Quality Improvement Program (NSQIP)
Participant Use File (2005-2008) was queried by Current Procedural
Terminology (American Medical Association, Chicago, Ill) code to identify
EVAR or OAR patients, who were grouped by CKD class as having mild
(CKD class 1 or 2), moderate (CKD class 3), or severe (CKD class 4 or 5) renal
disease. Propensity score analysis was performed to match OAR and EVAR
patients with mild CKD with those with moderate or severe CKD.
Comparative analysis of mortality and clinical outcomes was performed
based on CKD strata.
Results: We identiﬁed 8701 patients who were treated with EVAR (n =
5811) or OAR (n = 2890) of intact AAAs. Mild, moderate, and severe CKD
was present in 63%, 30%, and 7%, respectively. CKD increased (P < .01)
overall mortality, with rates of 1.7% (mild), 5.3% (moderate), and 7.7%
(severe) in unmatched patients undergoing EVAR or OAR. Operative
mortality rates in patients with severe CKD were as high as 6.2% for EVAR
and 10.3% for OAR. Severity of CKD was associated with increasing
frequency of risk factors; therefore, propensity matching to control for
comorbidities was performed, resulting in similar baseline clinical and
demographic features of patients with mild compared with those with
moderate or severe disease. In propensity-matched cohorts, moderate CKD
increased the risk of 30-day mortality for EVAR (1.9% mild vs 3.2%
moderate; P = .013) and OAR (3.1% mild vs 8.4% moderate; P < .0001).
Moderate CKD was also associated with increased morbidity in patients
treated with EVAR (8.3% mild vs 12.8% moderate; P < .0001) or OAR (25.2%
mild vs 32.4% moderate; P = .001). Similarly, severe CKD increased the risk
of 30-day mortality for EVAR (2.6% mild vs 5.7% severe; P = .0081) and OAR
(4.1% mild vs 9.9% severe; P = .0057). Severe CKD was also associated with
increased morbidity in patients treated with EVAR (10.6% mild vs 19.2%
severe; P < .0001) or OAR (31.1% mild vs 39.6% severe; P = .04).
Conclusions: The presence of moderate or severe CKD in patients
considered for AAA repair is associated with signiﬁcantly increased
mortality and therefore should ﬁgure prominently in clinical decision
making. The high mortality of AAA repair in patients with severe CKD is
such that elective repair in such patients is not advised, except in exten-
uating clinical circumstances.q Full articles available online at www.jvascsurg.org
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Matthew Mell, Julie J. White, Bradley B. Hill, Trevor Hastie, Ronald L.
Dalman
Objective: In addition to increased risks for aneurysm-related death,
previous studies have determined that all-cause mortality in abdominal
aortic aneurysm (AAA) patients is excessive and equivalent to that asso-
ciated with coronary heart disease. These studies largely preceded the
current era of coronary heart disease risk factor management, however,
and no recent study has examined contemporary mortality associated
with early AAA disease (aneurysm diameter between 3 and 5 cm). As part
of an ongoing natural history study of AAA, we report the mortality risk
associated with presence of early disease.
Methods: Participants were recruited from three distinct health care
systems in Northern California between 2006 and 2011. Aneurysm diam-
eter, demographic information, comorbidities, medication history, and
plasma for biomarker analysis were collected at study entry. Survival
status was determined at follow-up. Data were analyzed with t tests or c2
tests where appropriate. Freedom from death was calculated via Cox
proportional hazards modeling; the relevance of individual predictors on
mortality was determined by log-rank test.
Results: The study enrolled 634 AAA patients; age 76.4  8.0 years, aortic
diameter 3.86 0.7 cm. Participants were mostly male (88.8%), not current
smokers (81.6%), and taking statins (76.7%). Mean follow-up was 2.1  1.0
years. Estimated 1- and 3-year survival was 98.2% and 90.9%, respectively.
Factors independently associated with mortality included larger aneurysm
size (hazard ratio, 2.12; 95% conﬁdence interval, 1.26-3.57 for diameter
>4.0 cm) and diabetes (hazard ratio, 2.24; 95% conﬁdence interval, 1.12-
4.47). After adjusting for patient-level factors, health care system inde-
pendently predicted mortality.
Conclusions: Contemporary all-cause mortality for patients with early
AAA disease is lower than that previously reported. Further research is
warranted to determine important factors that contribute to improved
survival in early AAA disease.
Synchronous and metachronous thoracic aneurysms in patients
with abdominal aortic aneurysms
Rabih A. Chaer, Rogerio Vasoncelos, Luke K. Marone, George Al-Khoury,
Robert Y. Rhee, Jae S. Cho, Michel S. Makaroun
Objective: Although the association of thoracic aortic aneurysm (TAA) with
abdominal aortic aneurysm (AAA) is known, the exact magnitude of the
association has not been described. Our goal was to quantify the incidence
of TAA in patients with an AAA and assess predictive factors for its
diagnosis.
Methods: This was a retrospective review of all patients diagnosed with
AAA from 2000-2008. The subsequent development or diagnosis of a TAA
was noted and the association between AAA and TAA described.
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had a chest computed tomography (CT) during follow-up. 117 patients
(10.8%) had a synchronous and 136 (12.6%) a metachronous TAA. Mean
time to diagnosis was 2.3 years. Mean diameter was 4.7  1.4 cm for AAA,
and 4.7  1.0 for TAA. Indications for the chest CT were variable. Most
common were AAA (15%), pulmonary embolus (14%), and lung cancer
(11%). Only 38% of AAAs and 14% of TAAs were repaired during the study
period. Of all patients with known AAAwhowere found to have a TAA, 61/
253 (24%) underwent repair, had a rupture, or had a TAA >5.5 cm. At
a mean follow-up of 43.6 months, there were 79 deaths (7%): 7 AAA-
related and 13 from TAA ruptures. Predictors of TAA diagnosis by logistic
regression include African American race (odds ratio [OR] = 1.8; P = .02),
family history of TAA (OR = 7.6; P = .04), hypertension (OR = 1.7; P = .006),
and obesity (OR = 1.7; P = .006). Diabetes, infrarenal AAA location, and
smoking have a negative association.
Conclusions: TAAs are relatively common in patients with AAA. Routine or
targeted screening with a chest CT at the time of AAA diagnosis may be
indicated.
Brain computed tomography perfusion may help to detect
hemodynamic reconstitution and predict intracerebral hemorrhage
after carotid stenting
Shy-Chyi Chin, Chien-Hung Chang, Ting-Yu Chang, Ko-Lun Huang, Tai-
Cheng Wu, Jr-Rung Lin, Yeu-Jhy Chang, Tsong-Hai Lee
Objective: We wanted to examine whether brain computed tomography
(CT) perfusion can help to detect the reconstitution of cerebral hemody-
namics and predict intracerebral hemorrhage (ICH) after carotid stenting.
Methods: From September 2002 to October 2009, data of 114 patients with
carotid intervention were prospectively collected, and we retrospectively
identiﬁed a total of 108 consecutive patients with unilateral carotid
stenting. Brain CT perfusion was studied at three time points: 1 week
before, and 1 week and 6 months after stenting. Cerebral blood volume
(CBV), cerebral blood ﬂow, and time to peak (TTP) of brain CT perfusion
were examined at cortical and subcortical areas of middle cerebral artery
(MCA) and posterior cerebral artery territory. The CBV, cerebral blood ﬂow,
and TTP ratios of stenting side/nonstenting side were used for comparison.
The ﬂow direction of ophthalmic artery was detected by sonography, and
the presence of anterior communicating artery was examined on pre-
stenting cerebral angiogram.
Results:After carotid stenting, CBV and TTP ratios improved signiﬁcantly in
both MCA cortical and subcortical areas in patients with unilateral carotid
stenosis (P< .01) but not in patients with bilateral carotid stenosis. Patients
with reversed ophthalmic ﬂowhad better improvement of TTP in bothMCA
and posterior cerebral artery territories (P< .05) thanpatientswith forward
ﬂow. However, no signiﬁcant difference was found between patients with
andpatientswithout anterior communicating arterycollateral (P> .05). The
prestenting TTP ratio in MCA subcortical area was signiﬁcantly higher in
patients with poststenting ICH than patients without ICH (P = .0191).
Conclusions: Cerebral hemodynamics can be reconstituted within a few
days after carotid revascularization, especially in patients with reversed
ophthalmic ﬂow. Prolonged TTP in prestenting MCA subcortical area may
suggest a high risk of poststenting ICH.
Extracranial-intracranial bypass: Resurrection of a nearly extinct
operation
Ryan M. Gobble, Han Hoang, Jafar Jafar, Mark Adelman
Background: Giant intracranial artery aneurysms (GIAAs) are often not
amenable to neurosurgical clipping or endovascular coiling. Extracranial-
intracranial (EC-IC) bypass, a procedure that has been essentially aban-
doned for the treatment of intracranial ischemic disease, followed by
parent vessel occlusion, is often successful in treating these aneurysms.
Vascular surgeons should be familiar with this operation, especially in
centers with neurosurgical capability.
Methods: A retrospective review of patients treated from 1990 to 2010 at
New York University Medical Center was performed. Ofﬁce and hospital
records of all patients identiﬁed were reviewed with attention to the ageand sex of the patient, presenting symptoms, preoperative testing, proce-
dure performed, type of bypass conduit, graft patency, intraoperative and
postoperative complications, length of follow-up, and overall outcome. EC-
IC bypass was performed using a graft of great saphenous vein (GSV) or
radial artery (RA). The vascular surgeon harvested the vascular conduit,
tunneled the graft, and performed the extracranial anastomosis, and the
intracranial anastomosis was performed by the neurosurgeon.
Results: A total of 36 patients (14 men, 22 women) underwent 37 EC-IC
bypasses with 34 GSV and three RA grafts. The median age was 57 years
(interquartile range, 49-66 years), and the median follow-up was 53
months (interquartile range, 29-77 months). Aneurysm location was the
internal carotid artery in 30 patients, the basilar artery in three, and the
middle cerebral artery in four. All 37 aneurysms were excluded from the
cerebral circulation, with 33 grafts remaining patent at follow-up, as
determined by serial cerebral or magnetic resonance angiogram. At follow-
up, 33 of 34 of the GSV grafts (88%) and three of three (100%) of the RA
grafts were patent. There were two deaths (5.6%), despite patent grafts.
Postoperative graft occlusion led to homonymous hemianopsia in one
patient and temporary hemiparesis in another (5.6%). Graft occlusions
were asymptomatic in two patients.
Conclusions: EC-IC bypass is a safe and effective treatment for GIAAs, with
acceptable rates of morbidity (5.6%), mortality (5.6%), and graft patency
(89.2%). We suggest that the technique described in this report should be
routinely used for treatment of GIAAs in centers where neurosurgery and
vascular surgery services are available and should be considered a stan-
dard procedure in the armamentarium of the vascular surgeon.
The impact of diabetes on perioperative outcomes following lower-
extremity bypass surgery
Jessica B. Wallaert, Brian W. Nolan, Julie Adams, Andrew C. Stanley, Jens
Eldrup-Jorgensen, Jack L. Cronenwett, Philip P. Goodney
Objective: The effect of diabetes type (noninsulin dependent vs insulin
dependent) on outcomes after lower extremity bypass (LEB) has not been
clearly deﬁned. Therefore, we analyzed associations between diabetes
type and outcomes after LEB in patients with critical limb ischemia.
Methods:We performed a retrospective analysis of 1977 infrainguinal LEB
operations done for critical limb ischemia between 2003 and 2010 within
the Vascular Study Group of New England. Patients were categorized as
nondiabetic (ND), noninsulin dependent diabetic (NIDD), or insulin-
dependent diabetic (IDD) based on their preoperativemedication regimen.
Ourmain outcomemeasures were in-hospital mortality andmajor adverse
events (MAEs) e a composite outcome, including myocardial infarction,
dysrhythmia, congestive heart failure, wound infection, renal insufﬁciency,
andmajor amputation. We compared crude and adjusted rates of mortality
and MAEs using logistic regression across diabetes categories.
Results: Overall, 41% of patients were ND, 28% were NIDD, and 31% were
IDD. Crude rates of in-hospital mortality were similar across these groups
(1.7% vs 3.1% vs 2.1%; P = .211). Adjusted analyses accounting for differences
in patient characteristics showed that diabetes is not associated with
increased risk of in-hospital mortality. However, type of diabetes was
associated with a higher risk of MAEs in both crude (15.1% for ND; 21.1% for
NIDD; and 25.2% for IDD; P < .001) and adjusted analyses (odds ratio for
NIDD, 1.41; 95% conﬁdence interval, 1.2-1.7; odds ratio for IDD, 1.53; 95%
conﬁdence interval, 1.3-1.8).
Conclusions: Diabetes is a signiﬁcant contributor to the risk of post-
operative complications after LEB surgery, and insulin dependence is
associated with higher risk. Quality measures aimed at limiting compli-
cations after LEB may have the most impact if these initiatives are focused
on patients who are IDD.
Comparison of vein valve function following pharmacomechanical
thrombolysis vs simple catheter-directed thrombolysis for
iliofemoral deep vein thrombosis
David Vogel, M. Eileen Walsh, John T. Chen, Anthony J. Comerota
Background: Successful catheter-directed thrombolysis (CDT) for iliofe-
moral deep vein thrombosis (IFDVT) reduces post-thrombotic morbidity
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physicians for patients with IFDVT. Pharmacomechanical thrombolysis
(PMT) is also suggested to shorten treatment time and reduce the dose of
plasminogen activator. However, concern remains that mechanical devices
might damage vein valves. The purpose of this study is to examine
whether PMT adversely affects venous valve function compared to CDT
alone in IFDVT patients treated with catheter-based techniques.
Methods: Sixty-nine limbs in 54 patients (39 unilateral, 15 bilateral) who
underwent catheter-based treatment for IFDVT form the basis of this
study. Lytic success and degree of residual obstruction were analyzed by
reviewing postprocedural phlebograms. All patients underwent bilateral
postprocedure duplex to evaluate patency and valve function. Phlebo-
grams and venous duplex examinations were interpreted in a blinded
fashion. Limbs were analyzed based on the method of treatment: CDT
alone (n = 20), PMT using rheolytic thrombolysis (n = 14), and isolated
pharmacomechanical thrombolysis (n = 35). The validated outcome
measures were compared between the treatment groups.
Results: Sixty-nine limbs underwent CDT with or without PMT. The
average patient age was 47 years (range 16-78). Venous duplex was per-
formed 44.4 months (mean) post-treatment. Of the limbs treated with CDT
with drip technique, 65% demonstrated reﬂux vs 53% treatedwith PMT (P =
.42). There was no difference in long-term valve function between patients
treated with rheolytic and isolated pharmacomechanical thrombolysis. In
the bilateral group, 87% (13/15) demonstrated reﬂux in at least one limb. In
the unilateral group, 64% (25/39) had reﬂux in their treated limb and 36%
(14/39) in their contralateral limb. There was no correlation effect of
residual venous obstruction on valve function, although few patients had
>50% residual obstruction.
Conclusions: In patients undergoing catheter-based intervention for
IFDVT, PMT does not adversely affect valve function compared with CDT
alone. A higher than expected number of patients had reﬂux in their
uninvolved limb.
Analysis of the treatment of congenital vascular malformations
using a multidisciplinary approach
Michael E. Lidsky, Jovan N. Markovic, Michael J. Miller, Cynthia K. Shortell
Background: Vascular malformations are a rare and complex group of
lesions which may present serious pitfalls in diagnosis and management.
We sought to evaluate the efﬁcacy and safety of our imaging protocol andtherapeutic algorithm in the treatment of low-ﬂow and high-ﬂow vascular
malformations in a large series of patients.
Methods: A prospective database of all patients treated by the multidis-
ciplinary vascular malformation team at our institution between 2006 and
2011 was reviewed. Management decisions were based on patients' clin-
ical proﬁle as well as critical lesion characteristics, and included conser-
vative care, sclerotherapy, embolization, surgical resection, or
a combination of these modalities. Treatment goals and expectations were
established by the patient and physician at the time of initial evaluation.
An outcomes grading system based on patient- and physician-derived
treatment goals and assessment of response to management was applied
(1 = worse; 2 = unchanged, 3 = signiﬁcantly improved, 4 = completely
resolved), and postprocedural complications were identiﬁed.
Results: The 136 vascular malformations in 135 patients included 59
(43.7%) males and 76 (56.3%) females, ranging in age from under 1 year to
68 years (mean, 25.3 ± 17.0 years). In order to facilitate application of the
therapeutic algorithm, all patients underwent dynamic contrast-enhanced
magnetic resonance imaging to determine critical lesion characteristics,
including ﬂow quality and lesion extension. Of the 105 low-ﬂow vascular
malformations (LFVM), 23 (21.9%) were managed conservatively, 38
(36.2%) were treated with sclerotherapy (sodium tetradecyl sulfate, poli-
docanol, and/or ethanol), 18 (17.1%) were surgically resected, and eight
(7.6%) were managed with a combination of modalities. Of the 31 high-
ﬂow vascular malformations (HFVM), eight (25.8%) were managed
conservatively, eight (25.8%) were treated with transcatheter arterial
embolization, six (19.4%) required embolization followed by sclerotherapy,
and ﬁve (16.1%) were primarily resected. Patients in all groups managed
conservatively had minimal alteration in status. Response to sclerotherapy
in the LFVM group resulted in improvement in 32 (84.2%) patients, surgical
resection resulted in improvement in 16 (88.9%) patients, and combination
therapy resulted in improvement in eight (100%) patients. Treatment with
embolization in the HFVM group resulted in improvement in seven (87.5%)
patients, while combination therapy resulted in improvement in six
(100%), and surgical resection led to improvement in four (80%). Compli-
cations were observed in six (6.8%) patients treated for LFVMs (0 with
sodium tetradecyl sulfate or polidocanol, four with ethanol, two with
resection), and two (7.4%) patients treated for HFVMs with embolization or
combination therapy.
Conclusions: In this large cohort of vascular malformation patients,
implementation of the proposed diagnostic and therapeutic algorithms in
a multidisciplinary setting resulted in favorable outcomes with an
acceptable complication rate in this challenging patient population.
